214 related articles for article (PubMed ID: 19277009)
1. Adoptive transfer of human papillomavirus E7-specific CTL enhances tumor chemoresponse through the perforin/granzyme-mediated pathway.
Sin JI; Kim JM; Bae SH; Lee IH; Park JS; Ryoo HM
Mol Ther; 2009 May; 17(5):906-13. PubMed ID: 19277009
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic synergy of human papillomavirus E7 subunit vaccines plus cisplatin in an animal tumor model: causal involvement of increased sensitivity of cisplatin-treated tumors to CTL-mediated killing in therapeutic synergy.
Bae SH; Park YJ; Park JB; Choi YS; Kim MS; Sin JI
Clin Cancer Res; 2007 Jan; 13(1):341-9. PubMed ID: 17200373
[TBL] [Abstract][Full Text] [Related]
3. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
5. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
[TBL] [Abstract][Full Text] [Related]
6. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.
Caldwell SA; Ryan MH; McDuffie E; Abrams SI
J Immunol; 2003 Sep; 171(5):2402-12. PubMed ID: 12928387
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.
Vanhoutte VJ; McAulay KA; McCarrell E; Turner M; Crawford DH; Haque T
Immunology; 2009 Aug; 127(4):577-86. PubMed ID: 19604308
[TBL] [Abstract][Full Text] [Related]
8. Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses.
Getachew Y; Stout-Delgado H; Miller BC; Thiele DL
J Immunol; 2008 Dec; 181(11):7810-7. PubMed ID: 19017970
[TBL] [Abstract][Full Text] [Related]
9. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
Kafrouni MI; Brown GR; Thiele DL
J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
[TBL] [Abstract][Full Text] [Related]
10. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide.
Leggatt GR; Dunn LA; De Kluyver RL; Stewart T; Frazer IH
Immunol Cell Biol; 2002 Oct; 80(5):415-24. PubMed ID: 12225377
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476
[TBL] [Abstract][Full Text] [Related]
13. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo.
Aung S; Graham BS
J Immunol; 2000 Apr; 164(7):3487-93. PubMed ID: 10725701
[TBL] [Abstract][Full Text] [Related]
14. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs.
Cruz-Guilloty F; Pipkin ME; Djuretic IM; Levanon D; Lotem J; Lichtenheld MG; Groner Y; Rao A
J Exp Med; 2009 Jan; 206(1):51-9. PubMed ID: 19139168
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
Makrigiannis AP; Hoskin DW
J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
[TBL] [Abstract][Full Text] [Related]
16. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
17. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.
Yasukawa M; Ohminami H; Arai J; Kasahara Y; Ishida Y; Fujita S
Blood; 2000 Apr; 95(7):2352-5. PubMed ID: 10733506
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T lymphocyte perforin and Fas ligand working in concert even when Fas ligand lytic action is still not detectable.
Hassin D; Garber OG; Meiraz A; Schiffenbauer YS; Berke G
Immunology; 2011 Jun; 133(2):190-6. PubMed ID: 21517838
[TBL] [Abstract][Full Text] [Related]
19. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model.
Lu Y; Zhang Z; Liu Q; Liu B; Song X; Wang M; Zhao X; Zhao Q
Biol Pharm Bull; 2007 Jan; 30(1):150-6. PubMed ID: 17202676
[TBL] [Abstract][Full Text] [Related]
20. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
Yang S; Haluska FG
J Immunol; 2004 Apr; 172(7):4599-608. PubMed ID: 15034078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
